Cargando…

MicroRNAs in Medicinal Plants

Medicinal plant microRNAs (miRNAs) are an endogenous class of small RNA central to the posttranscriptional regulation of gene expression. Biosynthetic research has shown that the mature miRNAs in medicinal plants can be produced from either the standard messenger RNA splicing mechanism or the pre-ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Mingyang, Xu, Shiqiang, Mei, Yu, Li, Jingyu, Gu, Yan, Zhang, Wenting, Wang, Jihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500639/
https://www.ncbi.nlm.nih.gov/pubmed/36142389
http://dx.doi.org/10.3390/ijms231810477
_version_ 1784795269759500288
author Sun, Mingyang
Xu, Shiqiang
Mei, Yu
Li, Jingyu
Gu, Yan
Zhang, Wenting
Wang, Jihua
author_facet Sun, Mingyang
Xu, Shiqiang
Mei, Yu
Li, Jingyu
Gu, Yan
Zhang, Wenting
Wang, Jihua
author_sort Sun, Mingyang
collection PubMed
description Medicinal plant microRNAs (miRNAs) are an endogenous class of small RNA central to the posttranscriptional regulation of gene expression. Biosynthetic research has shown that the mature miRNAs in medicinal plants can be produced from either the standard messenger RNA splicing mechanism or the pre-ribosomal RNA splicing process. The medicinal plant miRNA function is separated into two levels: (1) the cross-kingdom level, which is the regulation of disease-related genes in animal cells by oral intake, and (2) the intra-kingdom level, which is the participation of metabolism, development, and stress adaptation in homologous or heterologous plants. Increasing research continues to enrich the biosynthesis and function of medicinal plant miRNAs. In this review, peer-reviewed papers on medicinal plant miRNAs published on the Web of Science were discussed, covering a total of 78 species. The feasibility of the emerging role of medicinal plant miRNAs in regulating animal gene function was critically evaluated. Staged progress in intra-kingdom miRNA research has only been found in a few medicinal plants, which may be mainly inhibited by their long growth cycle, high demand for growth environment, immature genetic transformation, and difficult RNA extraction. The present review clarifies the research significance, opportunities, and challenges of medicinal plant miRNAs in drug development and agricultural production. The discussion of the latest results furthers the understanding of medicinal plant miRNAs and helps the rational design of the corresponding miRNA/target genes functional modules.
format Online
Article
Text
id pubmed-9500639
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95006392022-09-24 MicroRNAs in Medicinal Plants Sun, Mingyang Xu, Shiqiang Mei, Yu Li, Jingyu Gu, Yan Zhang, Wenting Wang, Jihua Int J Mol Sci Review Medicinal plant microRNAs (miRNAs) are an endogenous class of small RNA central to the posttranscriptional regulation of gene expression. Biosynthetic research has shown that the mature miRNAs in medicinal plants can be produced from either the standard messenger RNA splicing mechanism or the pre-ribosomal RNA splicing process. The medicinal plant miRNA function is separated into two levels: (1) the cross-kingdom level, which is the regulation of disease-related genes in animal cells by oral intake, and (2) the intra-kingdom level, which is the participation of metabolism, development, and stress adaptation in homologous or heterologous plants. Increasing research continues to enrich the biosynthesis and function of medicinal plant miRNAs. In this review, peer-reviewed papers on medicinal plant miRNAs published on the Web of Science were discussed, covering a total of 78 species. The feasibility of the emerging role of medicinal plant miRNAs in regulating animal gene function was critically evaluated. Staged progress in intra-kingdom miRNA research has only been found in a few medicinal plants, which may be mainly inhibited by their long growth cycle, high demand for growth environment, immature genetic transformation, and difficult RNA extraction. The present review clarifies the research significance, opportunities, and challenges of medicinal plant miRNAs in drug development and agricultural production. The discussion of the latest results furthers the understanding of medicinal plant miRNAs and helps the rational design of the corresponding miRNA/target genes functional modules. MDPI 2022-09-09 /pmc/articles/PMC9500639/ /pubmed/36142389 http://dx.doi.org/10.3390/ijms231810477 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sun, Mingyang
Xu, Shiqiang
Mei, Yu
Li, Jingyu
Gu, Yan
Zhang, Wenting
Wang, Jihua
MicroRNAs in Medicinal Plants
title MicroRNAs in Medicinal Plants
title_full MicroRNAs in Medicinal Plants
title_fullStr MicroRNAs in Medicinal Plants
title_full_unstemmed MicroRNAs in Medicinal Plants
title_short MicroRNAs in Medicinal Plants
title_sort micrornas in medicinal plants
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500639/
https://www.ncbi.nlm.nih.gov/pubmed/36142389
http://dx.doi.org/10.3390/ijms231810477
work_keys_str_mv AT sunmingyang micrornasinmedicinalplants
AT xushiqiang micrornasinmedicinalplants
AT meiyu micrornasinmedicinalplants
AT lijingyu micrornasinmedicinalplants
AT guyan micrornasinmedicinalplants
AT zhangwenting micrornasinmedicinalplants
AT wangjihua micrornasinmedicinalplants